查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1833576

标准笔针市场预测至 2032 年：按药物类型、适应症、针头尺寸、可用性、购买模式、最终用户和地区的全球分析

Standard Pen Needles Market Forecasts to 2032 - Global Analysis By Drug Type (Insulin, Growth Hormone, GLP-1, and Other Drug Types), Disease Indication, Needle Size, Usability, Mode of Purchase, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，预计 2025 年全球标准笔针市场规模将达到 16.9 亿美元，到 2032 年将达到 30.6 亿美元，预测期内复合年增长率为 8.8%。

标准笔针是细小的一次性医用针头，可连接到胰岛素笔和类似的注射器。它们能够实现皮下精准可控的药物输送。它们有多种长度和粗细可供选择，旨在提高患者舒适度和给药准确性。其一次性使用的特性有助于防止感染和污染，使其成为自行注射治疗的安全便捷的选择。

根据国际糖尿病联盟（IDF）的数据，2023年将有超过5.3亿成年人罹患糖尿病，预计未来几十年这一数字还会增加。

患者对胰岛素笔的偏好日益增长

糖尿病等慢性疾病的日益流行，推动了对便捷给药系统的需求。胰岛素笔因其易于使用、便于携带以及与传统注射器相比注射疼痛减轻等优点，正日益受到欢迎。笔针设计的技术进步正在提高患者的舒适度和剂量的准确性。随着医疗保健朝向个人化治疗方向发展，胰岛素笔正成为日常疾病管理的必需品。老年人口的成长和诊断率的提高进一步推动了胰岛素笔的应用。由于糖尿病照护和糖尿病教育的普及，新兴市场的胰岛素笔应用也日益普及。

过渡到安全针头

向安全笔针的过渡给製造商带来了监管和成本相关的挑战。这些设备需要符合严格的安全标准，包括防止针刺伤的机制。增加安全功能通常会增加製造的复杂性和成本，进而影响利润率。小型企业面临核准ISO和FDA等全球认证要求的挑战。针头追踪和处置感测器等智慧技术的整合也进一步增加了监管审查。这些因素可能会减缓创新，并推迟产品在竞争激烈的市场中的上市。

自我管理的趋势日益增长

日益增长的自我管理疗法趋势为标准注射笔针头创造了新的机会。随着患者越来越多地选择在家中管理慢性疾病，对易于使用、可靠的注射器的需求也日益增长。针头人体工学和超薄设计的创新正在提升舒适度并减少焦虑。由于卫生方面的考虑和感染控制通讯协定，一次性注射笔针头越来越受欢迎。製造商正在探索可生物降解的材料和智慧包装，以符合永续性目标。远端医疗平台和远端监控技术也支持了这一转变，这些技术可以提高患者的自主性。

安全装置严格规定

安全设备的法律规范正变得越来越复杂和严格。当局在核准新的针头技术之前，需要大量的临床检验和记录。剂量追踪和连接等数位化功能的兴起，也带来了额外的合规挑战。供应链中断和材料短缺会使监管时间更加复杂。缺乏强大监管团队的公司可能难以应对不断变化的标准，尤其是在跨境市场。这些限制阻碍了创新，并限制了市场扩张的速度。

COVID-19的影响：

封锁和医疗保健优先顺序的调整推迟了常规糖尿病护理和选择性治疗。然而，这场危机加速了居家医疗和自行注射的普及。监管机构对包括注射笔针头在内的基本医疗设备引入了快速核准。数位健康平台和远距会诊支持了疫情期间医疗服务的连续性。后疫情时代策略的重点是供应链的韧性、自动化和分散式生产，以确保不间断的取得。

预计胰岛素市场将成为预测期内最大的市场

预计在预测期内，胰岛素细分市场将占据最大的市场份额，这得益于全球糖尿病负担的不断增加以及胰岛素疗法的广泛应用。胰岛素输送系统的技术进步提高了注射的准确性和患者的依从性。用于胰岛素笔的注射针头也变得越来越复杂，例如长度更短、规格更细。越来越多的医疗保健提供者建议使用胰岛素笔，以更好地控制血糖并减少注射错误。随着胰岛素治疗日益个人化，对相容注射针头的需求持续激增。

预计家庭医疗保健领域在预测期内将实现最高复合年增长率

预计家庭医疗保健领域将在预测期内实现最高成长率。不断上涨的医疗成本和病患对居家照护的偏好推动了这一转变。注射笔针头是自行注射的必备工具，已成为家庭慢性病管理的核心。包装和针头安全的技术创新使这些设备更容易被非临床使用者使用。远端医疗和远端监控技术正在强化分散式医疗的趋势。随着医疗保健体系的不断发展，家庭医疗保健已成为注射笔针头製造商的关键成长引擎。

比最大的地区

预计亚太地区将在预测期内占据最大的市场份额。快速的都市化和不断上升的糖尿病盛行率正在推动中国、印度和日本等国的需求。政府推动本地生产和负担得起的医疗保健的措施正在促进市场渗透。该地区正在见证数位医疗工具和智慧注射器的普及。全球品牌与区域参与者之间的策略伙伴关係正在加速技术转移。对医疗基础设施的投资和社会意识宣传活动正在进一步扩大用户群。

复合年增长率最高的地区：

预计北美在预测期内的复合年增长率最高。该地区在技术创新方面处于领先地位，例如先进的针头设计和安全功能的整合。监管机构正在简化下一代注射器的核准流程，以加快其商业化进程。自我护理和远距医疗管理的广泛普及推动了对易于使用的注射笔针头的需求。医疗保健提供者正在利用数据分析和物联网来优化慢性病的治疗通讯协定。强大的报销体系和强劲的研发投入正在巩固北美在该领域的领先地位。

目标应用

  • 免洗笔针
  • 可重复使用的笔针

免费客製化服务：

此报告的订阅者可以选择以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球标准笔针市场（依药物类型）

  • 胰岛素
  • 生长激素
  • GLP-1
  • 其他药物类型

6. 全球标准笔针市场（按适应症）

  • 糖尿病
  • 荷尔蒙缺乏
  • 肥胖

7. 全球标准笔针市场（依针头尺寸）

  • 4毫米
  • 5毫米
  • 6毫米
  • 8毫米
  • 12毫米

8. 全球标准笔针市场依使用性别

  • 免洗笔针
  • 可重复使用的笔针

9. 全球标准笔针市场按购买类型

  • 零售
  • 线上购买
  • 非零售通路

10. 全球标准笔针市场（依最终用户）

  • 医院
  • 家庭医疗保健
  • 诊所
  • 其他最终用户

第 11 章全球标准笔针头市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章：企业概况

  • Becton, Dickinson and Company
  • Berpu Medical Technology Co., Ltd.
  • Novo Nordisk A/S
  • HTL-STREFA
  • Embecta Corp.
  • GlucoRx Limited
  • Ypsomed AG
  • ARKRAY, Inc.
  • B. Braun SE
  • AdvaCare Pharma
  • Owen Mumford Ltd.
  • Allison Medical, Inc.
  • Terumo Corporation
  • UltiMed, Inc.
  • NIPRO Corporation
Product Code: SMRC31409

According to Stratistics MRC, the Global Standard Pen Needles Market is accounted for $1.69 billion in 2025 and is expected to reach $3.06 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Standard pen needles are thin, single-use medical needles that connect to insulin pens or similar injection devices. They enable accurate and controlled delivery of medications under the skin. Available in various lengths and thicknesses, these needles are designed to enhance patient comfort and dosing precision. Their disposable nature helps prevent infection and contamination, making them a safe and convenient option for self-administering injectable treatments.

According to the International Diabetes Federation (IDF), over 530 million adults were living with diabetes in 2023, and this number is expected to rise in the coming decades.

Market Dynamics:

Driver:

Increasing patient preference for insulin pens

The growing prevalence of chronic illnesses like diabetes is fueling demand for convenient drug delivery systems. Insulin pens are gaining popularity due to their ease of use, portability, and reduced injection pain compared to traditional syringes. Technological advancements in pen needle design are improving patient comfort and dosage accuracy. As healthcare shifts toward personalized treatment, insulin pens are becoming integral to daily disease management. The rise in elderly populations and improved diagnostic rates are further boosting adoption. Emerging markets are witnessing increased uptake due to expanding access to diabetes care and education.

Restraint:

Shift towards safety pen needles

The transition toward safety pen needles is introducing regulatory and cost-related hurdles for manufacturers. These devices require compliance with stringent safety standards, including mechanisms to prevent needlestick injuries. Incorporating safety features often increases production complexity and cost, impacting profit margins. Smaller players face challenges in meeting global certification requirements like ISO and FDA approvals. The integration of smart technologies such as needle tracking and disposal sensors adds further regulatory scrutiny. These factors can slow down innovation and delay product launches in competitive markets.

Opportunity:

Rising trend of self-administration

The growing trend of self-administered therapies is creating new opportunities for standard pen needles. Patients are increasingly managing chronic conditions at home, driving demand for user-friendly and reliable injection devices. Innovations in needle ergonomics and ultra-thin designs are enhancing comfort and reducing anxiety. Disposable pen needles are gaining traction due to hygiene concerns and infection control protocols. Manufacturers are exploring biodegradable materials and smart packaging to align with sustainability goals. This shift is also supported by telehealth platforms and remote monitoring technologies that empower patient autonomy.

Threat:

Stringent regulations on safety devices

Regulatory frameworks governing safety devices are becoming more complex and demanding. Authorities require extensive clinical validation and documentation before approving new needle technologies. The rise of digital features like dose tracking and connectivity adds layers of compliance challenges. Supply chain disruptions and material shortages can further complicate regulatory timelines. Companies without robust regulatory teams may struggle to navigate evolving standards, especially in cross-border markets. These constraints can hinder innovation and limit the speed of market expansion.

Covid-19 Impact:

Lockdowns and healthcare reprioritization delayed routine diabetes care and elective treatments. However, the crisis accelerated the adoption of home-based care and self-injection practices. Regulatory bodies introduced fast-track approvals for essential medical devices, including pen needles. Digital health platforms and remote consultations supported continuity of care during the pandemic. Post-COVID strategies now emphasize supply chain resilience, automation, and decentralized production to ensure uninterrupted access.

The insulin segment is expected to be the largest during the forecast period

The insulin segment is expected to account for the largest market share during the forecast period, driven by the rising global burden of diabetes and the widespread use of insulin therapy. Technological improvements in insulin delivery systems are enhancing precision and patient adherence. Pen needles designed for insulin pens are becoming more sophisticated, with features like shorter lengths and finer gauges. Healthcare providers are increasingly recommending insulin pens for better glycemic control and reduced injection errors. As insulin therapy becomes more personalized, demand for compatible pen needles continues to surge.

The home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate. Rising healthcare costs and patient preference for at-home treatment are driving this shift. Pen needles are essential tools for self-injection, making them central to home-based chronic disease management. Innovations in packaging and needle safety are making these devices more accessible for non-clinical users. Telemedicine and remote monitoring technologies are reinforcing the trend toward decentralized care. As healthcare systems evolve, home healthcare is emerging as a key growth engine for pen needle manufacturers.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share. Rapid urbanization and increasing diabetes prevalence are fuelling demand across countries like China, India, and Japan. Government initiatives promoting local manufacturing and affordable healthcare are boosting market penetration. The region is witnessing strong adoption of digital health tools and smart injection devices. Strategic collaborations between global brands and regional players are accelerating technology transfer. Investments in healthcare infrastructure and public awareness campaigns are further expanding the user base.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR. The region leads in technological innovation, with advanced needle designs and integrated safety features. Regulatory agencies are streamlining approval processes for next-gen injection devices, encouraging rapid commercialization. High adoption of self-care and remote health management is driving demand for user-friendly pen needles. Healthcare providers are leveraging data analytics and IoT to optimize chronic disease treatment protocols. Robust reimbursement frameworks and strong R&D investments are reinforcing North America's leadership in this space.

Key players in the market

Some of the key players in Standard Pen Needles Market include Becton, Dickinson and Company, Berpu Medical Technology Co., Ltd., Novo Nordisk A/S, HTL-STREFA, Embecta Corp., GlucoRx Limited, Ypsomed AG, ARKRAY, Inc., B. Braun SE, AdvaCarePharma, Owen Mumford Ltd., Allison Medical, Inc., Terumo Corporation, UltiMed, Inc., and NIPRO Corporation.

Key Developments:

In September2025, BD (Becton, Dickinson and Company) announced a pharmacy automation partnership with Henry Ford Health to develop the health system pharmacy of the future, with an initial focus on a robotic solution that will enable patients to pick up select prescriptions at their convenience 24 hours a day, seven days a week.

In May2025, Novo Nordisk and Septerna, Inc. announced an exclusive global collaboration and license agreement to discover, develop and commercialise oral small molecule medicines for obesity, type 2 diabetes and other cardiometabolic diseases.

DrugTypes Covered:

  • Insulin
  • Growth Hormone
  • GLP-1
  • Other Drug Types

Disease Indications Covered:

  • Diabetes
  • Hormone Deficiency
  • Obesity

Needle Sizes Covered:

  • 4 mm
  • 5 mm
  • 6 mm
  • 8 mm
  • 12 mm

UsabilitiesCovered:

  • Disposable Pen Needles
  • Reusable Pen Needles

Mode of Purchases Covered:

  • Retail
  • Online Purchase
  • Non-Retail Channels

End Users Covered:

  • Hospitals
  • Home Healthcare
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Standard Pen Needles Market, By Drug Type

  • 5.1 Introduction
  • 5.2 Insulin
  • 5.3 Growth Hormone
  • 5.4 GLP-1
  • 5.5 Other Drug Types

6 Global Standard Pen Needles Market, By Disease Indication

  • 6.1 Introduction
  • 6.2 Diabetes
  • 6.3 Hormone Deficiency
  • 6.4 Obesity

7 Global Standard Pen Needles Market, By Needle Size

  • 7.1 Introduction
  • 7.2 4 mm
  • 7.3 5 mm
  • 7.4 6 mm
  • 7.5 8 mm
  • 7.6 12 mm

8 Global Standard Pen Needles Market, By Usability

  • 8.1 Introduction
  • 8.2 Disposable Pen Needles
  • 8.3 Reusable Pen Needles

9 Global Standard Pen Needles Market, By Mode of Purchase

  • 9.1 Introduction
  • 9.2 Retail
  • 9.3 Online Purchase
  • 9.4 Non-Retail Channels

10 Global Standard Pen Needles Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Home Healthcare
  • 10.4 Clinics
  • 10.5 Other End Users

11 Global Standard Pen Needles Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Becton, Dickinson and Company
  • 13.2 Berpu Medical Technology Co., Ltd.
  • 13.3 Novo Nordisk A/S
  • 13.4 HTL-STREFA
  • 13.5 Embecta Corp.
  • 13.6 GlucoRx Limited
  • 13.7 Ypsomed AG
  • 13.8 ARKRAY, Inc.
  • 13.9 B. Braun SE
  • 13.10 AdvaCare Pharma
  • 13.11 Owen Mumford Ltd.
  • 13.12 Allison Medical, Inc.
  • 13.13 Terumo Corporation
  • 13.14 UltiMed, Inc.
  • 13.15 NIPRO Corporation

List of Tables

  • Table 1 Global Standard Pen Needles Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Standard Pen Needles Market Outlook, By Drug Type (2024-2032) ($MN)
  • Table 3 Global Standard Pen Needles Market Outlook, By Insulin (2024-2032) ($MN)
  • Table 4 Global Standard Pen Needles Market Outlook, By Growth Hormone (2024-2032) ($MN)
  • Table 5 Global Standard Pen Needles Market Outlook, By GLP-1 (2024-2032) ($MN)
  • Table 6 Global Standard Pen Needles Market Outlook, By Other Drug Types (2024-2032) ($MN)
  • Table 7 Global Standard Pen Needles Market Outlook, By Disease Indication (2024-2032) ($MN)
  • Table 8 Global Standard Pen Needles Market Outlook, By Diabetes (2024-2032) ($MN)
  • Table 9 Global Standard Pen Needles Market Outlook, By Hormone Deficiency (2024-2032) ($MN)
  • Table 10 Global Standard Pen Needles Market Outlook, By Obesity (2024-2032) ($MN)
  • Table 11 Global Standard Pen Needles Market Outlook, By Needle Size (2024-2032) ($MN)
  • Table 12 Global Standard Pen Needles Market Outlook, By 4 mm (2024-2032) ($MN)
  • Table 13 Global Standard Pen Needles Market Outlook, By 5 mm (2024-2032) ($MN)
  • Table 14 Global Standard Pen Needles Market Outlook, By 6 mm (2024-2032) ($MN)
  • Table 15 Global Standard Pen Needles Market Outlook, By 8 mm (2024-2032) ($MN)
  • Table 16 Global Standard Pen Needles Market Outlook, By 12 mm (2024-2032) ($MN)
  • Table 17 Global Standard Pen Needles Market Outlook, By Usability (2024-2032) ($MN)
  • Table 18 Global Standard Pen Needles Market Outlook, By Disposable Pen Needles (2024-2032) ($MN)
  • Table 19 Global Standard Pen Needles Market Outlook, By Reusable Pen Needles (2024-2032) ($MN)
  • Table 20 Global Standard Pen Needles Market Outlook, By Mode of Purchase (2024-2032) ($MN)
  • Table 21 Global Standard Pen Needles Market Outlook, By Retail (2024-2032) ($MN)
  • Table 22 Global Standard Pen Needles Market Outlook, By Online Purchase (2024-2032) ($MN)
  • Table 23 Global Standard Pen Needles Market Outlook, By Non-Retail Channels (2024-2032) ($MN)
  • Table 24 Global Standard Pen Needles Market Outlook, By End User (2024-2032) ($MN)
  • Table 25 Global Standard Pen Needles Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 26 Global Standard Pen Needles Market Outlook, By Home Healthcare (2024-2032) ($MN)
  • Table 27 Global Standard Pen Needles Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 28 Global Standard Pen Needles Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.